Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: MaxCyte Inc., 3 years.
MaxCyte Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | MaxCyte Inc. | Grant or award | +30,421 | — | — |
| Jun 18, 2025 | MaxCyte Inc. | Grant or award | +29,210 | — | — |
| Jan 27, 2025 | MaxCyte Inc. | Option exercise | +3,000 | $2.93 | $8,790 |
| Jan 27, 2025 | MaxCyte Inc. | Open-market sale | −3,000 | $4.65 | $13,950 |
| Dec 26, 2024 | MaxCyte Inc. | Option exercise | +3,000 | $2.93 | $8,790 |
| Dec 26, 2024 | MaxCyte Inc. | Open-market sale | −3,000 | $4.01 | $12,030 |
| Dec 9, 2024 | MaxCyte Inc. | Option exercise | +891 | $2.93 | $2,611 |
| Dec 9, 2024 | MaxCyte Inc. | Option exercise | +1,121 | $1.64 | $1,838 |
| Dec 9, 2024 | MaxCyte Inc. | Option exercise | +483 | $2.93 | $1,415 |
| Dec 9, 2024 | MaxCyte Inc. | Open-market sale | −2,495 | $3.79 | $9,456 |
| Dec 6, 2024 | MaxCyte Inc. | Option exercise | +505 | $2.93 | $1,480 |
| Dec 6, 2024 | MaxCyte Inc. | Open-market sale | −505 | $3.70 | $1,869 |
| Oct 28, 2024 | MaxCyte Inc. | Option exercise | +3,000 | $2.93 | $8,790 |
| Oct 28, 2024 | MaxCyte Inc. | Open-market sale | −3,000 | $3.72 | $11,160 |
| Sep 26, 2024 | MaxCyte Inc. | Option exercise | +3,000 | $2.93 | $8,790 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.